INCB 99280

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB 99280, covering 2025-02-18 to 2025-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors [Phase 1]